{"id":7506,"date":"2024-08-31T13:09:02","date_gmt":"2024-08-31T05:09:02","guid":{"rendered":"https:\/\/regask.com\/?p=7506"},"modified":"2024-09-25T02:19:23","modified_gmt":"2024-09-24T18:19:23","slug":"fda-workshop-2024-zu-generika","status":"publish","type":"post","link":"https:\/\/regask.com\/de\/fda-2024-generic-drug-workshop\/","title":{"rendered":"F\u00f6rderung der Entwicklung von Generika durch die US-amerikanische Arzneimittelzulassungsbeh\u00f6rde FDA im Jahr 2024 \u2026"},"content":{"rendered":"<p>Das Center for Drug Evaluation and Research (CDER) Small Business and Industry Assistance (SBIA) der FDA wird am 24. und 25. September 2024 den mit Spannung erwarteten 2024 Advancing Generic Drug Development Workshop ausrichten.<\/p>\n<p>Dieser Workshop bietet Fachleuten der Generikabranche eine wichtige Gelegenheit, sich \u00fcber die neuesten wissenschaftlichen und regulatorischen Fortschritte zu informieren. Ob pers\u00f6nlich oder virtuell \u2013 die Teilnehmer gewinnen wertvolle Erkenntnisse und ein besseres Verst\u00e4ndnis f\u00fcr die zuk\u00fcnftige Entwicklung von Generika.<\/p>\n<p><strong>Workshop-Schwerpunkte<\/strong><\/p>\n<p>Der Workshop befasst sich mit wichtigen Themen, die f\u00fcr die Weiterentwicklung der Generikaindustrie von wesentlicher Bedeutung sind, darunter:<\/p>\n<ul>\n<li><strong>Fortschritte in der In-vitro-Charakterisierung<\/strong>: Entdecken Sie die neuesten Methoden zur Verbesserung der In-vitro-Charakterisierung von Generika.<\/li>\n<li><strong>Forschung zur Beratungsentwicklung<\/strong>: Verstehen Sie die Forschungsinitiativen der FDA, die auf die Entwicklung von Leitlinien f\u00fcr komplexe Produkte abzielen.<\/li>\n<li><strong>Sicherstellung von Qualit\u00e4t und Effizienz<\/strong>: Informieren Sie sich \u00fcber die laufenden Bem\u00fchungen zur Gew\u00e4hrleistung einer effizienten Entwicklung und hohen Qualit\u00e4t von Generika.<\/li>\n<\/ul>\n<p>Die Teilnehmer erhalten au\u00dferdem ein tieferes Verst\u00e4ndnis f\u00fcr die Auswirkungen des Wissenschafts- und Forschungsprogramms Generic Drug User Fee Amendments (GDUFA) der FDA auf die Entwicklung, Regulierung und Zulassung von Generika.<\/p>\n<p><strong>Workshop-Zeitplan<\/strong><\/p>\n<ul>\n<li><strong>Tag 1<\/strong>: 24. September 2024, 8:30 \u2013 16:35 Uhr ET<\/li>\n<li><strong>Tag 2<\/strong>: 25. September 2024, 9:00 \u2013 16:15 Uhr ET<\/li>\n<\/ul>\n<a href=\"https:\/\/regask.com\/de\/kontakt\/\" target=\"_blank\" class=\"button primary is-link is-medium\" rel=\"noopener\" >\n\t\t<span>Mehr lesen<\/span>\n\t<\/a>\n\n<p>\u00a9Dieser RegAlert wird herausgegeben von RegASK<\/p>","protected":false},"excerpt":{"rendered":"<p>The FDA&#8217;s Center for Drug Evaluation and Research (CDER) Small Business and Industry Assistance (SBIA) is set to host the highly anticipated 2024 Advancing Generic Drug Development Workshop on September 24-25, 2024. This workshop is an essential opportunity for professionals in the generic drug industry to stay informed on the latest scientific and regulatory advancements&#8230;.<\/p>","protected":false},"author":22,"featured_media":7511,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[35],"tags":[177,193,299,481,482,483],"class_list":["post-7506","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma-biotech-latest-insights","tag-labelling","tag-fda","tag-regulatory-intelligence","tag-generic-drugs","tag-webinar","tag-workshop"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.4 (Yoast SEO v28.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FDA&#039;s 2024 Generic Drug Workshop: Key Insights | RegASK<\/title>\n<meta name=\"description\" content=\"The FDA&#039;s 2024 Advancing Generic Drug Development Workshop is essential for industry professionals. Get the key takeaways with RegASK.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/de\/fda-workshop-2024-zu-generika\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"US FDA&#039;s 2024 Advancing Generic Drug Development Workshop: A Must-Attend Event for Industry Professionals\" \/>\n<meta property=\"og:description\" content=\"The FDA&#039;s 2024 Advancing Generic Drug Development Workshop is essential for industry professionals. Get the key takeaways with RegASK.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/de\/fda-workshop-2024-zu-generika\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-31T05:09:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-24T18:19:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/08\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Divvya Behal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Divvya Behal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/\"},\"author\":{\"name\":\"Divvya Behal\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/194dd7cb5a4908baaeea7bd8e3dac5d0\"},\"headline\":\"US FDA&#8217;s 2024 Advancing Generic Drug Development &hellip;\",\"datePublished\":\"2024-08-31T05:09:02+00:00\",\"dateModified\":\"2024-09-24T18:19:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/\"},\"wordCount\":232,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png\",\"keywords\":[\"Labelling\",\"FDA\",\"Regulatory Intelligence\",\"Generic Drugs\",\"Webinar\",\"Workshop\"],\"articleSection\":[\"Pharma and Biotech\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/\",\"name\":\"FDA's 2024 Generic Drug Workshop: Key Insights | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png\",\"datePublished\":\"2024-08-31T05:09:02+00:00\",\"dateModified\":\"2024-09-24T18:19:23+00:00\",\"description\":\"The FDA's 2024 Advancing Generic Drug Development Workshop is essential for industry professionals. Get the key takeaways with RegASK.\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png\",\"width\":1600,\"height\":1200,\"caption\":\"Us Fda 2024 Advancing Generic Drug Development Workshop Must Attend Event Industry Professionals\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@RegASK\",\"https:\\\/\\\/www.crunchbase.com\\\/organization\\\/regask\",\"https:\\\/\\\/www.bloomberg.com\\\/profile\\\/company\\\/1691237D:SP\",\"https:\\\/\\\/pitchbook.com\\\/profiles\\\/company\\\/265004-02\",\"https:\\\/\\\/www.cbinsights.com\\\/company\\\/RegASK\",\"https:\\\/\\\/vimeo.com\\\/RegASK\"],\"legalName\":\"RegASK PTE. LTD.\",\"foundingDate\":\"2018\",\"slogan\":\"Empowering Smarter Regulatory Decisions\",\"description\":\"Agentic AI regulatory intelligence and workflow orchestration platform for Life Sciences and Consumer Products. RegASK combines vertical LLMs, multi-agent AI architecture, and a global community of 1,800+ subject matter experts to deliver regulatory horizon scanning, impact analysis, compliance workflow automation, and audit-ready outputs across 160+ countries.\",\"areaServed\":\"Worldwide\",\"founder\":{\"@type\":\"Person\",\"name\":\"Caroline Shleifer\",\"jobTitle\":\"Founder & CEO\"},\"address\":{\"@type\":\"PostalAddress\",\"streetAddress\":\"79 Science Park Drive, #06-01, Cintech IV\",\"addressLocality\":\"Singapore\",\"postalCode\":\"118264\",\"addressCountry\":\"SG\"},\"contactPoint\":{\"@type\":\"ContactPoint\",\"telephone\":\"+65 6817 6290\",\"contactType\":\"customer service\",\"availableLanguage\":[\"English\",\"French\",\"Japanese\",\"Spanish\",\"Chinese\",\"German\"]},\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":50,\"maxValue\":100},\"knowsAbout\":[\"Regulatory Intelligence\",\"Regulatory Compliance\",\"Regulatory Affairs\",\"Workflow Orchestration\",\"Life Sciences Regulation\",\"Consumer Products Regulation\",\"AI-Driven Compliance\"],\"hasCertification\":[{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 42001:2023\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27001:2022\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27701\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27018:2019\"},{\"@type\":\"Certification\",\"name\":\"SOC 2 Type II\"}]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/194dd7cb5a4908baaeea7bd8e3dac5d0\",\"name\":\"Divvya Behal\",\"sameAs\":[\"https:\\\/\\\/regask.com\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FDA-Workshop zu Generika 2024: Wichtige Erkenntnisse | RegASK","description":"Der FDA-Workshop \u201eAdvancing Generic Drug Development 2024\u201c ist f\u00fcr Branchenexperten unverzichtbar. Die wichtigsten Erkenntnisse finden Sie mit RegASK.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/de\/fda-workshop-2024-zu-generika\/","og_locale":"de_DE","og_type":"article","og_title":"US FDA's 2024 Advancing Generic Drug Development Workshop: A Must-Attend Event for Industry Professionals","og_description":"The FDA's 2024 Advancing Generic Drug Development Workshop is essential for industry professionals. Get the key takeaways with RegASK.","og_url":"https:\/\/regask.com\/de\/fda-workshop-2024-zu-generika\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2024-08-31T05:09:02+00:00","article_modified_time":"2024-09-24T18:19:23+00:00","og_image":[{"width":1600,"height":1200,"url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/08\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png","type":"image\/png"}],"author":"Divvya Behal","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Divvya Behal","Est. reading time":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/#article","isPartOf":{"@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/"},"author":{"name":"Divvya Behal","@id":"https:\/\/regask.com\/#\/schema\/person\/194dd7cb5a4908baaeea7bd8e3dac5d0"},"headline":"US FDA&#8217;s 2024 Advancing Generic Drug Development &hellip;","datePublished":"2024-08-31T05:09:02+00:00","dateModified":"2024-09-24T18:19:23+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/"},"wordCount":232,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/08\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png","keywords":["Labelling","FDA","Regulatory Intelligence","Generic Drugs","Webinar","Workshop"],"articleSection":["Pharma and Biotech"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/","url":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/","name":"FDA-Workshop zu Generika 2024: Wichtige Erkenntnisse | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/08\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png","datePublished":"2024-08-31T05:09:02+00:00","dateModified":"2024-09-24T18:19:23+00:00","description":"Der FDA-Workshop \u201eAdvancing Generic Drug Development 2024\u201c ist f\u00fcr Branchenexperten unverzichtbar. Die wichtigsten Erkenntnisse finden Sie mit RegASK.","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/fda-2024-generic-drug-workshop\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/08\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/08\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png","width":1600,"height":1200,"caption":"Us Fda 2024 Advancing Generic Drug Development Workshop Must Attend Event Industry Professionals"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Das regulatorische KI-Betriebssystem f\u00fcr leistungsstarke Teams","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/@RegASK","https:\/\/www.crunchbase.com\/organization\/regask","https:\/\/www.bloomberg.com\/profile\/company\/1691237D:SP","https:\/\/pitchbook.com\/profiles\/company\/265004-02","https:\/\/www.cbinsights.com\/company\/RegASK","https:\/\/vimeo.com\/RegASK"],"legalName":"RegASK PTE. LTD.","foundingDate":"2018","slogan":"Empowering Smarter Regulatory Decisions","description":"Agentic AI ist eine Plattform f\u00fcr regulatorische Analysen und Workflow-Orchestrierung in den Bereichen Life Sciences und Konsumg\u00fcter. RegASK kombiniert vertikale LLMs, eine Multiagenten-KI-Architektur und eine globale Community von \u00fcber 1.800 Fachexperten, um regulatorische Zukunftsprognosen, Wirkungsanalysen, die Automatisierung von Compliance-Workflows und auditfertige Ergebnisse in \u00fcber 160 L\u00e4ndern bereitzustellen.","areaServed":"Worldwide","founder":{"@type":"Person","name":"Caroline Shleifer","jobTitle":"Founder & CEO"},"address":{"@type":"PostalAddress","streetAddress":"79 Science Park Drive, #06-01, Cintech IV","addressLocality":"Singapore","postalCode":"118264","addressCountry":"SG"},"contactPoint":{"@type":"ContactPoint","telephone":"+65 6817 6290","contactType":"customer service","availableLanguage":["English","French","Japanese","Spanish","Chinese","German"]},"numberOfEmployees":{"@type":"QuantitativeValue","minValue":50,"maxValue":100},"knowsAbout":["Regulatory Intelligence","Regulatory Compliance","Regulatory Affairs","Workflow Orchestration","Life Sciences Regulation","Consumer Products Regulation","AI-Driven Compliance"],"hasCertification":[{"@type":"Certification","name":"ISO\/IEC 42001:2023"},{"@type":"Certification","name":"ISO\/IEC 27001:2022"},{"@type":"Certification","name":"ISO\/IEC 27701"},{"@type":"Certification","name":"ISO\/IEC 27018:2019"},{"@type":"Certification","name":"SOC 2 Type II"}]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/194dd7cb5a4908baaeea7bd8e3dac5d0","name":"Divvya Behal","sameAs":["https:\/\/regask.com"]}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/7506","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/comments?post=7506"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/7506\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media\/7511"}],"wp:attachment":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media?parent=7506"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/categories?post=7506"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/tags?post=7506"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}